Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aetna PBM Spin-Off Floated As Insurer Uncertainties Over Health Reform Grow

This article was originally published in The Pink Sheet Daily

Executive Summary

The three biggest standalone PBMs are considered likeliest suitors if a sale occurs.

You may also be interested in...

Medco Weighing Opportunities For Consolidation In PBM Space – CEO Snow

Acquiring an in-house pharmacy benefit manager from a health plan "could be the right thing for Medco" if done at the "right price," CEO David Snow commented during the firm's first quarter earnings call April 29

Express Scripts Purchase Deal For NextRx Includes 10-Year PBM Contract With WellPoint

With the acquisition of the largest plan-owned pharmacy benefit manager, Express Scripts will move to second place among the big stand-alone PBMs, ahead of CVS Caremark.

Aetna Brings Mail-Order Rx In-House With Acquisition Of Eckerd Facility

Aetna will handle all mail-order prescriptions for its members through a facility purchased from Eckerd


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts